Paper Details
- Home
- Paper Details
Intravenous dolasetron mesilate in the prevention of postoperative nausea and vomiting in females undergoing gynecological surgery.
Author: BrownR A, D'HollanderA, DiemunschP, HahneW F, NavéS, PaxtonL, SchoefflerP, WesselP
Original Abstract of the Article :
STUDY OBJECTIVE: To evaluate a range of doses of intravenous (i.v.) dolasetron mesilate, in preventing postoperative nausea and vomiting (PONV). DESIGN: Double-blind, placebo-controlled, randomized, multicenter trial. SETTING: Ten hospitals and/or surgical centers. PATIENTS: 281 women undergoing ...See full text at original site
Dr.Camel's Paper Summary Blogラクダ博士について
ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。
* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。
引用元:
https://doi.org/10.1016/s0952-8180(97)00063-9
データ提供:米国国立医学図書館(NLM)
Intravenous Dolasetron for Postoperative Nausea and Vomiting
Postoperative nausea and vomiting (PONV) is a common and often unpleasant side effect of surgery. This study investigates the effectiveness of intravenous (i.v.) dolasetron mesilate in preventing PONV in women undergoing gynecologic surgery. It's like discovering a new type of desert plant that can soothe the stomach and prevent discomfort.
The researchers conducted a randomized controlled trial, administering different doses of dolasetron mesilate to patients undergoing gynecologic surgery. They monitored the patients for 24 hours after surgery, assessing the incidence and severity of PONV. It's like observing the effects of a new type of desert herb on a group of travelers, measuring their reactions and well-being.
Dolasetron's Effectiveness in Preventing PONV
The study showed that dolasetron mesilate was effective in reducing PONV in women undergoing gynecologic surgery. It was well tolerated and did not cause significant adverse effects. It's like finding a hidden oasis that provides both relief from discomfort and nourishment for those who seek it.
Relief from Postoperative Discomfort
This research provides valuable insights into the potential of dolasetron mesilate for preventing PONV. It's like finding a new source of fresh water in a desert, providing relief and comfort for those who have been struggling with this common side effect of surgery.
Dr.Camel's Conclusion
This study provides strong evidence that dolasetron mesilate is an effective and well-tolerated treatment for preventing PONV in women undergoing gynecologic surgery. It's a welcome addition to the medical toolbox, providing a much-needed solution for a common and often debilitating side effect of surgery.
Date :
- Date Completed 1997-10-30
- Date Revised 2019-09-14
Further Info :
Related Literature
English
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.